Happy to circulate our paper on the evolving landscape of ICIs and ADC’s in early BC. Lots of exciting research in this area for our patients!
#bcsm@prarthnavb@UNC_Lineberger
@tony_breu Great thread.. i believe it is the interaction between cancer cells and surrounding cells/matrix, making the theory of seed/soil as a possible explanation
JUST IN: Big news in metastatic breast cancer: HER-2 directed therapy (Trastuzumab Deruxtecan, HER-2 ADC) may now have a place in HER2 IHC 1+/2+: DESTINY-Breast04 met PFS/OS endpoints!
@OncoAlert@DFCI_BreastOnc@AstraZeneca
https://t.co/drCxQc4bK5
"“The more time physicians spent with
their patients on coping issues, the better the patients were doing in terms of quality of life and depression.” -Michael Hoerger, PhD, MSCR" https://t.co/dnPfAT9TcW via @ascopost